Artal Group’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,500,000
| Closed | -$1.92M | – | 63 |
|
|
2024
Q2 | $1.92M | Hold |
2,500,000
| – | – | 0.05% | 76 |
|
|
2024
Q1 | $7.63M | Hold |
2,500,000
| – | – | 0.19% | 50 |
|
|
2023
Q4 | $8.05M | Hold |
2,500,000
| – | – | 0.27% | 38 |
|
|
2023
Q3 | $9.6M | Hold |
2,500,000
| – | – | 0.41% | 37 |
|
|
2023
Q2 | $8.2M | Hold |
2,500,000
| – | – | 0.25% | 54 |
|
|
2023
Q1 | $6.45M | Hold |
2,500,000
| – | – | 0.38% | 55 |
|
|
2022
Q4 | $4.65M | Hold |
2,500,000
| – | – | 0.26% | 62 |
|
|
2022
Q3 | $4.6M | Hold |
2,500,000
| – | – | 0.2% | 59 |
|
|
2022
Q2 | $5.38M | Hold |
2,500,000
| – | – | 0.29% | 54 |
|
|
2022
Q1 | $7.85M | Hold |
2,500,000
| – | – | 0.33% | 58 |
|
|
2021
Q4 | $8.03M | Hold |
2,500,000
| – | – | 0.22% | 72 |
|
|
2021
Q3 | $8.4M | Hold |
2,500,000
| – | – | 0.19% | 83 |
|
|
2021
Q2 | $9.78M | Hold |
2,500,000
| – | – | 0.2% | 84 |
|
|
2021
Q1 | $10.1M | Hold |
2,500,000
| – | – | 0.18% | 86 |
|
|
2020
Q4 | $5.78M | Hold |
2,500,000
| – | – | 0.12% | 95 |
|
|
2020
Q3 | $14.4M | Buy |
+2,500,000
| New | +$14.4M | 0.35% | 52 |
|